Send feedback

ADAR p.Leu165Pro

c.494T>C · rs1697924081 · VCV2284034

Uncertain significance Single submitter
Classification
Uncertain significance
ClinVar
Review
Single submitter ★☆☆☆
ClinVar · 1 submitter
AlphaMissense
likely pathogenic
0.7164 · ACMG-weighted
gnomAD v4.1
Rare
very rare (popmax 0.000169%, nfe)
Missense predictors
2/2 damaging
AlphaMissense, SaProt · REVEL indeterminate
Conditions
1
Inborn genetic diseases

Computational evidence

Protein change
AlphaMissense0.7164likely pathogenic
REVEL0.576indeterminate
SaProtLLR -15.98damaging
⇒ AlphaMissense and SaProt both call this damaging; REVEL is indeterminate.
Splicing
SpliceAI<0.2no splice effect predicted · four deltas, not one · how we know
Constraint at this position
ConservationphyloP 11GERP 1.7, phastCons 1
Regional constrainto/e 0.96unconstrained · MANE · 6,556 bp · p 0.34 · regional, not allelic
Overall
CADD25.3PHRED · no single calibrated threshold — expert panels disagree

ClinVar classifies this uncertain; the computational predictors unanimously lean damaging — a triage signal, not a reclassification

AlphaMissense carries the ACMG weight for missense; REVEL and SaProt are independent agreement signals.

Population frequency

gnomAD v4.1 · exomes + genomes
Grpmax group 0.000169% European (non-Finnish) · 2/1,180,034 alleles
Filtering AF 2.8e-05% ClinGen BA1/BS1 input FAF95, joint · FAF99 1.1e-05%
Overall 0.000248% 4/1,614,194 alleles · very rare exomes 4/1,461,892 · genomes 0/152,302 · joint denominator
Ancestry group Frequency 1 in
Remaining individualsnot grpmax-eligible 0.0016% 62,510
Finnishnot grpmax-eligible 0.00156% 64,030
European (non-Finnish)grpmax 0.000169% 590,016

Remaining individuals shows a higher raw frequency than the grpmax group above it. gnomAD excludes bottlenecked groups — Finnish, Ashkenazi Jewish, Amish and “Remaining individuals” — from grpmax, because founder effects make their frequencies unrepresentative for filtering. The table is sorted by frequency, so an excluded group can sit above the grpmax row.

Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.

Variant & gene context

Gene
ADAR
Protein
p.Leu165Pro
Coding
c.494T>C
MANE Select
NM_001111
dbSNP
rs1697924081
Type
single nucleotide variant
Location
chr1:154602148 (GRCh38)
Gene constraint
LOEUF 0.449 · pLI 1.00 (gnomAD)
Structure
AlphaFold pLDDT 68.86 · 24 PDB
Residue 165
the z-binding 1 domain; the 'interaction with z-dna' region; an α-helix
Full ADAR gene report on Sugi Atlas → Gene function, pathways, protein structure, interactions & more

Similar variants

Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →

Cite Sugi Variant

Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/adar-p-leu165pro (accessed [today's date]).

Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown